Non-interventional Study to Evaluate Patient and Healthcare Provider Satisfaction of Daratumumab Use in the Treatment of First-line Daratumumab, Lenalidomide, Dexamethasone (DRd) Multiple Myeloma Patients in Germany Depending on Application Route (sc or iv)
Condition(s):Multiple Myeloma; Newly Diagnosed; Transplant Ineligible; Patient Satisfaction; Patient Preference; Personal SatisfactionLast Updated:August 16, 2023Active, not recruiting